Suchergebnisse - "Siegel, Eric R"

PubPharm (8)

1

In Vivo and In Vitro Efficacy of Trastuzumab Deruxtecan in Uterine Serous Carcinoma

enthalten in: Molecular cancer therapeutics | 2023

von Mutlu, L. | Manavella, D. | Bellone, S. | +19

2

Trastuzumab tolerability in the treatment of advanced (stage III-IV) or recurrent uterine serous carcinomas that overexpress HER2/neu

enthalten in: Gynecologic oncology | 2021

von Tymon-Rosario, J. | Siegel, E. | Bellone, S. | +14

3

Dual antivascular function of human fibulin-3 variant, a potential new drug discovery strategy for glioblastoma

enthalten in: Cancer science | 2020

von Ke, C. | Luo, J. | Cen, Z. | +14

4

Germline Genetic Variants in TEK, ANGPT1, ANGPT2, MMP9, FGF2 and VEGFA Are Associated with Pathologic Complete Response to Bevacizumab in Breast Cancer Patients

enthalten in: PloS one | 2017

von Makhoul, I. | Todorova, V. | Siegel, E. | +10

5

Cell context-dependent dual effects of EFEMP1 stabilizes subpopulation equilibrium in responding to changes of in vivo growth environment

enthalten in: Oncotarget | 2015

von Hu, Y. | Ke, C. | Ru, N. | +6

6

Differential sensitivity to platinum-based chemotherapy in primary uterine serous papillary carcinoma cell lines with high vs low HER-2/neu expression in vitro

enthalten in: American journal of obstetrics and gynecology | 2010

von Cross, S. | Cocco, E. | Bellone, S. | +7

7

Amplification of c-erbB2 oncogene : a major prognostic indicator in uterine serous papillary carcinoma

enthalten in: Cancer | 2005

von Santin, A. | Bellone, S. | Van Stedum, S. | +7

8

Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer : expression of lymphangiogenic markers is associated with advanced-stage disease

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2005

von Kaushal, V. | Mukunyadzi, P. | Dennis, R. | +3

1
[1]